Table 2.
All countries combined |
Within-country OR variation |
||||||
---|---|---|---|---|---|---|---|
Range |
GxC interaction2 |
||||||
F:M OR (95% CI) | Min | Max | % in dominant direction | % p ≤ .05 in dominant direction | χ2 | (n)3 | |
I. Mood disorders | |||||||
Major depressive disorder | 1.9* (1.8–2.0) | 1.6 | 2.4 | 100.0 | 100.0 | 29.3* | (15) |
Dysthymic disorder | 1.9* (1.6–2.2) | 1.3 | 3.8 | 100.0 | 70.0 | 13.0 | (10) |
Bipolar disorder | 0.9 (0.8–1.0) | 0.6 | 1.1 | 83.3 | 20.0 | 8.1 | (6) |
Any mood disorder | 1.8* (1.7–1.8) | 1.5 | 2.5 | 100.0 | 100.0 | 47.7* | (15) |
II. Anxiety disorders | |||||||
Panic disorder | 1.9* (1.7–2.2) | 1.2 | 3.4 | 100.0 | 66.7 | 15.8 | (12) |
Generalized anxiety disorder | 1.7* (1.5–1.9) | 0.7 | 2.7 | 86.7 | 76.9 | 23.7* | (15) |
Agoraphobia | 2.0* (1.7–2.3) | 1.4 | 4.6 | 100.0 | 62.5 | 18.5 | (8) |
Social phobia | 1.3* (1.2–1.4) | 1.1 | 2.0 | 100.0 | 46.2 | 13.8 | (13) |
Specific phobia | 2.0* (1.9–2.2) | 1.3 | 3.1 | 100.0 | 100.0 | 39.3* | (12) |
Separation anxiety disorder | 1.6* (1.4–1.8) | 1.4 | 2.0 | 100.0 | 75.0 | 3.8 | (4) |
Post-traumatic stress disorder | 2.6* (2.2–2.9) | 1.3 | 6.4 | 100.0 | 78.6 | 30.6* | (14) |
Any anxiety disorder | 1.7* (1.6–1.8) | 1.2 | 3.2 | 100.0 | 86.7 | 41.2* | (15) |
III. Externalizing disorders | |||||||
Attention-deficit/hyperactivity disorder | 0.6* (0.5–0.8) | 0.3 | 0.6 | 100.0 | 20.0 | 6.9 | (5) |
Conduct disorder | 0.5* (0.4–0.7) | 0.3 | 0.6 | 100.0 | 100.0 | 29.5* | (3) |
Intermittent explosive disorder | 0.7* (0.6–0.8) | 0.4 | 0.8 | 100.0 | 33.3 | 5.3 | (6) |
Oppositional-defiant disorder | 0.8* (0.6–1.0) | 0.5 | 0.8 | 100.0 | 33.3 | 18.2* | (3) |
Any externalizing disorder | 0.7* (0.6–0.8) | 0.3 | 1.4 | 83.3 | 40.0 | 7.2 | (12) |
IV. Substance disorders | |||||||
Alcohol abuse | 0.2* (0.2–0.3) | 0.1 | 0.4 | 100.0 | 100.0 | 128.6* | (15) |
Alcohol dependence | 0.3* (0.3–0.4) | 0.1 | 0.4 | 100.0 | 100.0 | 95.6* | (11) |
Drug abuse or dependence | 0.4* (0.3–0.4) | 0.1 | 0.4 | 100.0 | 100.0 | 35.3* | (5) |
Any substance disorder | 0.3* (0.2–0.3) | 0.1 | 0.4 | 100.0 | 100.0 | 141.6* | (14) |
V. Any disorder | 1.1* (1.1–1.2) | 0.7 | 2.2 | 66.7 | 70.0 | 111.5* | (15) |
Significant at the .05 level, two-sided test
Based on discrete-time survival models that used respondent cohort (age at interview), sex, and person-year to predict first onset of each disorder both separately in each country and pooled across all countries.
GxC=gender-by-country; based on pooled cross-national survival model that included an interaction between gender and the dummy variables for country.
The number of countries differs across outcomes because not all disorders were assessed in all countries. The pooled results for any mood disorder, any anxiety disorder, any externalizing disorder, and any substance disorder pooled whatever disorders in the relevant category existed in the country across countries even though the set sometimes differed across countries.